FRM
Fox Run Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,333
| Closed | -$611K | – | 1074 |
|
|
2024
Q1 | $611K | Sell |
43,333
-3,263
| -7% | -$46K | 0.13% | 295 |
|
|
2023
Q4 | $486K | Buy |
+46,596
| New | +$486K | 0.12% | 307 |
|
|
2023
Q2 | – | Sell |
-41,299
| Closed | -$365K | – | 954 |
|
|
2023
Q1 | $365K | Buy |
+41,299
| New | +$365K | 0.12% | 341 |
|
|
2022
Q3 | – | Sell |
-23,001
| Closed | -$173K | – | 820 |
|
|
2022
Q2 | $173K | Buy |
+23,001
| New | +$173K | 0.09% | 428 |
|
|
2020
Q4 | – | Sell |
-10,646
| Closed | -$96K | – | 288 |
|
|
2020
Q3 | $96K | Buy |
+10,646
| New | +$96K | 0.24% | 146 |
|
|
2020
Q1 | – | Sell |
-30,174
| Closed | -$296K | – | 351 |
|
|
2019
Q4 | $296K | Buy |
+30,174
| New | +$296K | 0.24% | 204 |
|
|
2019
Q2 | – | Sell |
-16,205
| Closed | -$254K | – | 619 |
|
|
2019
Q1 | $254K | Buy |
16,205
+1,418
| +10% | +$22.2K | 0.14% | 320 |
|
|
2018
Q4 | $228K | Buy |
+14,787
| New | +$228K | 0.12% | 367 |
|
|
2018
Q3 | – | Sell |
-33,600
| Closed | -$817K | – | 816 |
|
|
2018
Q2 | $817K | Buy |
33,600
+22,784
| +211% | +$554K | 0.26% | 80 |
|
|
2018
Q1 | $185K | Buy |
+10,816
| New | +$185K | 0.04% | 643 |
|
|
2017
Q2 | – | Sell |
-27,500
| Closed | -$882K | – | 830 |
|
|
2017
Q1 | $882K | Buy |
+27,500
| New | +$882K | 0.36% | 40 |
|
|
2016
Q3 | – | Sell |
-4,400
| Closed | -$221K | – | 689 |
|
|
2016
Q2 | $221K | Buy |
+4,400
| New | +$221K | 0.11% | 399 |
|